Research article · 3 May 2019
Research articlePublished 31 Jul 2019
Phytotherapy and Physiotherapy in Multiple Sclerosis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system (CNS). Its cause is still unknown but it is connected to certain demyelination of the axons in the brain and spinal cord. Despite the medical advances, in the 21st century, multiple sclerosis remains an incurable disease. In order to stop the MS progression, we should concentrate our efforts on reversing the process of demyelination and on improving the transmission of nerve impulses along CNS. Methods: The effects of a treatment with a daily intake of an alcohol extract of snowdrop or a snowdrop-derived drug containing nivaline and other biological active substances (BAS), and an alcohol extract of Atropa belladonna or Atropa belladonna-derived drug combined with regular electro-magnetic physiotherapeutic procedures were analysed in patients with MS. Results: The daily administration of nivaline and atropine in combination with regular electromagnetic physiotherapeutic procedures showed potential to reverse the course of MS manifesting itself with a clinical remission of patients with MS. Conclusion: Our findings suggest that the treatment regimen proposed here possesses the potential to stop the process of demyelination in the CNS and stimulate the process of remyelination in MS patients thus achieving a state of clinical remission.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Other · 2016
Innovative Physiotherapy and Continuity of Care in People with Multiple Sclerosis: A Randomized Controlled Trial and a Qualitative Study
Commentary · 31 Oct 2023
A Multicenter Prospective Study Investigating the Long-term Safety and Efficacy of Immunomodulatory Therapies in Relapsing-Remitting Multiple Sclerosis
Research article · 10 Dec 2021
The Prevalence, Epidemiology, Patient Well Being and Adherence to Therapy and Disease Burden of Multiple Sclerosis in Jordan
Conference abstract · 2020
Limited value of relative risk reductions for assessing the benefits of disease modifying therapies for multiple sclerosis
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kaniskov VL”
- BylineArticles whose byline prints “Iliev IE”

